278 related articles for article (PubMed ID: 33369444)
41. [Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities].
Liu X; Zhang L; Zou Y; Chang L; Wei W; Ruan M; Chen Y; Yang W; Chen X; Guo Y; Wang S; Liu T; Zhang J; Liu F; Qi B; An W; Zhu X
Zhonghua Er Ke Za Zhi; 2016 Feb; 54(2):126-30. PubMed ID: 26875463
[TBL] [Abstract][Full Text] [Related]
42. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
[TBL] [Abstract][Full Text] [Related]
43. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
[TBL] [Abstract][Full Text] [Related]
44. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.
Schiffman JD; Wang Y; McPherson LA; Welch K; Zhang N; Davis R; Lacayo NJ; Dahl GV; Faham M; Ford JM; Ji HP
Cancer Genet Cytogenet; 2009 Aug; 193(1):9-18. PubMed ID: 19602459
[TBL] [Abstract][Full Text] [Related]
45. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
[TBL] [Abstract][Full Text] [Related]
46. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract][Full Text] [Related]
47. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
[TBL] [Abstract][Full Text] [Related]
48.
Lopes BA; Barbosa TC; Souza BKS; Poubel CP; Pombo-de-Oliveira MS; Emerenciano M;
Cancer Prev Res (Phila); 2017 Dec; 10(12):738-744. PubMed ID: 28947432
[TBL] [Abstract][Full Text] [Related]
49. IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.
Kuiper RP; Waanders E; van der Velden VH; van Reijmersdal SV; Venkatachalam R; Scheijen B; Sonneveld E; van Dongen JJ; Veerman AJ; van Leeuwen FN; van Kessel AG; Hoogerbrugge PM
Leukemia; 2010 Jul; 24(7):1258-64. PubMed ID: 20445578
[TBL] [Abstract][Full Text] [Related]
50. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.
Ghazavi F; Clappier E; Lammens T; Suciu S; Caye A; Zegrari S; Bakkus M; Grardel N; Benoit Y; Bertrand Y; Minckes O; Costa V; Ferster A; Mazingue F; Plat G; Plouvier E; Poirée M; Uyttebroeck A; van der Werff-Ten Bosch J; Yakouben K; Helsmoortel H; Meul M; Van Roy N; Philippé J; Speleman F; Cavé H; Van Vlierberghe P; De Moerloose B
Haematologica; 2015 Oct; 100(10):1311-9. PubMed ID: 26137961
[TBL] [Abstract][Full Text] [Related]
51. The prognostic value of IKZF1
Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
[TBL] [Abstract][Full Text] [Related]
52. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
[TBL] [Abstract][Full Text] [Related]
53. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
[TBL] [Abstract][Full Text] [Related]
54. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel.
Aoe M; Ishida H; Matsubara T; Karakawa S; Kawaguchi H; Fujiwara K; Kanamitsu K; Washio K; Okada K; Shibakura M; Shimada A
Int J Lab Hematol; 2018 Aug; 40(4):427-436. PubMed ID: 29575541
[TBL] [Abstract][Full Text] [Related]
56. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract][Full Text] [Related]
57. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
[TBL] [Abstract][Full Text] [Related]
58. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
[TBL] [Abstract][Full Text] [Related]
59.
Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
[No Abstract] [Full Text] [Related]
60. Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia.
Kathiravan M; Singh M; Bhatia P; Trehan A; Varma N; Sachdeva MS; Bansal D; Jain R; Naseem S
Leuk Lymphoma; 2019 Feb; 60(2):433-441. PubMed ID: 29966470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]